The Valley Desk

ArticleTherapeutic advances in respiratory diseasePublished

Antifibrotic therapy combined with pulmonary vasodilator therapy may improve survival in patients with pulmonary fibrosis and pulmonary hypertension: a retrospective cohort study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Lewis Katz School of Medicine, Temple University Hospital, with Temple Health, Temple University linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Therapeutic advances in respiratory disease
Published
Subject terms
Humans; Hypertension, Pulmonary; Pulmonary Fibrosis; Vasodilator Agents; Treatment Outcome; Drug Therapy, Combination; Lung Transplantation; Retrospective Studies; Recovery of Function; Exercise Tolerance; Time Factors; Aged
PubMed ID
40083194
PubMed Central ID
PMC11907552
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal